stock
ORIC · Oric Pharmaceuticals, Inc.
What Oric Pharmaceuticals, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live ORIC price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ORIC.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 103,652,656 as of 2026-07-27 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -36.8%
- ROA
- -34.7%
Health
- Current ratio
- 13.2x
- Debt/equity
- —
Deep value
- NCAV
- $250.27M
- NCAV per share
- $2.41
- Price/NCAV
- Locked
- NNWC
- $14.05M
- NNWC per share
- $0.14
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$45.30M | -$41.49M | 10-Q filed 2026-08-03 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$39.62M | -$35.77M | 10-Q filed 2026-05-04 |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$34.55M | -$30.50M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$36.67M | -$32.59M | 10-Q filed 2025-11-13 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$39.06M | -$36.35M | 10-Q filed 2026-08-03 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$32.72M | -$30.02M | 10-Q filed 2026-05-04 |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$39.57M | -$36.31M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$38.32M | -$34.57M | 10-Q filed 2025-11-13 |
- Assets
- $404.69M
- Equity
- $381.26M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$143.00M | -$129.47M | -$111.68M |
| 2024-12-31 | — | -$142.90M | -$127.85M | -$113.85M |
| 2023-12-31 | — | -$110.78M | -$100.70M | -$86.54M |
| 2022-12-31 | — | -$91.77M | -$89.12M | -$77.22M |
| 2021-12-31 | — | -$78.87M | -$78.72M | -$60.48M |
| 2020-12-31 | — | -$74.19M | -$73.70M | -$45.94M |
| 2019-12-31 | — | -$28.57M | -$26.88M | -$24.30M |
| 2018-12-31 | — | -$22.37M | -$21.36M | -$21.21M |
Company filings
1 offering filing in 12 months · since Mon Feb 23
events
5% owners ()
VIKING GLOBAL INVESTORS LP
Stake update
Venrock Healthcare Capital Partners III, L.P.
Stake update
Point72 Asset Management, L.P.
Stake update
T. Rowe Price Associates, Inc.
Passive stake
Pfizer Inc. (IRS Identification No.: 13-5315170)
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Heyman Richard A.
Director
Sale$86,524Oct 2, 5:50 PM ET
Piscitelli Dominic
Chief Financial Officer
Sale$181,258Sep 29, 7:16 PM ET
Piscitelli Dominic
Chief Financial Officer
Sale$8,103Sep 25, 7:59 PM ET
Piscitelli Dominic
Chief Financial Officer
Sale$1,053,814Aug 28, 4:11 PM ET
Heyman Richard A.
Director
Sale$157,462Jul 28, 4:15 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Viking Global
Period Tue 30 Jun 2026
0.2%Trimmed
News
Stories that named ORIC, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about ORIC.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on ORIC come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ORIC board